Eliquis and Tardive dyskinesia - a phase IV clinical study of FDA data

Summary:

Tardive dyskinesia is reported as a side effect among people who take Eliquis (apixaban), especially for people who are female, 60+ old, also take Crestor, and have Malignant peritoneal neoplasm.

The phase IV clinical study analyzes which people have Tardive dyskinesia when taking Eliquis. It is created by eHealthMe based on reports of 189,425 people who have side effects when taking Eliquis from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,859 Eliquis users. Check the latest studies of Eliquis.

What is Tardive dyskinesia?

Tardive dyskinesia (a disorder that involves involuntary movements) is found to be associated with 764 drugs and 1,321 conditions by eHealthMe. Check the latest studies of Tardive dyskinesia.

On Jul, 04, 2026

189,425 people reported to have side effects when taking Eliquis.
Among them, 23 people (0.01%) have Tardive dyskinesia.

Among these 23 people:

What is the gender of people who have Tardive dyskinesia when taking Eliquis? *

female: 76.47 %
male: 23.53 %

What is the age of people who have Tardive dyskinesia when taking Eliquis? *

What are other drugs people take besides Eliquis? *

What are other side effects people have besides Tardive dyskinesia? *

High Blood Pressure: 7 people, 30.43%
Insomnia (sleeplessness): 6 people, 26.09%
Weakness: 6 people, 26.09%
Fatigue (feeling of tiredness): 6 people, 26.09%
Dehydration (dryness resulting from the removal of water): 5 people, 21.74%
Abdominal Discomfort: 5 people, 21.74%
Hepatic Mass: 4 people, 17.39%
Dry Skin: 4 people, 17.39%
Milia (dead skin becomes trapped in small pockets at the surface of the skin or mouth): 4 people, 17.39%
Joint Pain: 4 people, 17.39%

What are the existing conditions these people have? *

Trichorrhexis (a condition in which the hairs break): 4 people, 17.39%
Blood Magnesium Decreased: 4 people, 17.39%
Onychoclasis (breaking of the nails): 4 people, 17.39%
Neoplasm Malignant (cancer tumour): 4 people, 17.39%
Nausea (feeling of having an urge to vomit): 4 people, 17.39%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 4 people, 17.39%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 13.04%
Hair Loss: 3 people, 13.04%
Dyslipidaemia (abnormal amount of lipids): 2 people, 8.70%
Cardiac Failure: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and have Tardive dyskinesia?

- Check whether Tardive dyskinesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eliquis:

Eliquis (191,859 reports)

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tardive dyskinesia:

Tardive dyskinesia (764 drugs)

Browse all the conditions that are associated with Tardive dyskinesia:

Tardive dyskinesia (1,321 conditions)

Related publications that referenced our studies

Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Eliquis) and Eliquis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.